The exon-junction complex (EJC) performs essential RNA processing tasks 1-5 . Here, we describe the first human disorder, thrombocytopenia with absent radii (TAR) 6 , caused by deficiency in one of the four EJC subunits. Compound inheritance of a rare null allele and one of two low-frequency SNPs in the regulatory regions of RBM8A, encoding the Y14 subunit of EJC, causes TAR. We found that this inheritance mechanism explained 53 of 55 cases (P < 5 × 10 −228 ) of the rare congenital malformation syndrome. Of the 53 cases with this inheritance pattern, 51 carried a submicroscopic deletion of 1q21.1 that has previously been associated with TAR 7 , and two carried a truncation or frameshift null mutation in RBM8A. We show that the two regulatory SNPs result in diminished RBM8A transcription in vitro and that Y14 expression is reduced in platelets from individuals with TAR. Our data implicate Y14 insufficiency and, presumably, an EJC defect as the cause of TAR syndrome.
l e t t e r s (Supplementary Note), and we suggest that, in this instance, there is a different causative allele that we have not been able to identify. In the 25 trios where the deletion in the child was not a de novo event, we confirmed that the deletion and the newly identified SNPs were inherited from different parents (Supplementary Table 1 ). The minor allele frequencies (MAFs) of the 5′ UTR and intronic SNPs were 3.05% and 0.42%, respectively, in 7,504 healthy individuals of the Cambridge BioResource 10 (Supplementary Note), and the deletion a 145. 20 Mb The RBM8A transcript is shown in genomic coordinates with the sequence encoding the RNA-binding domain (RRM) indicated by the orange bar above the transcript. (c) We identified two low-frequency regulatory SNPs in 53 out of a total of 55 TAR cases studied. The first, at chr. 1: 145,507,646 (rs139428292), with a G or A allele, is located in the 5′ UTR of RBM8A and has a population MAF of 3.05% (dark blue). The second, at chr. 1: 145,507,765, with a G or C allele, is located in the first intron of RBM8A and has a population MAF of 0.41% (green). Thirty-nine TAR cases carried the minor allele of the 5′ UTR SNP on one chromosome and the 1q21.1 deletion on the other; 12 TAR cases carried the minor allele of the intronic SNP on one chromosome and the 1q21.1 deletion on the other. The compound inheritance of the 1q21.1 deletion and one of the two regulatory SNPs was strongly associated with TAR with P < 5 × 10 −228 . Two additional TAR cases were found to have the minor allele of the 5′ UTR SNP in combination with either a frameshift insertion (purple) or a nonsense mutation (light blue) instead of the 1q21. npg l e t t e r s was absent from 5,919 shared healthy controls of the Wellcome Trust Case Control Consortium 10 . Thus, the concurrent presence of one of the two noncoding SNPs on one allele and the 1q21.1 deletion at the other is strongly associated with TAR syndrome, with an estimated P value of < 5 × 10 −228 (Supplementary Note). Next, we sequenced all exons of RBM8A in two additional TAR cases who did not carry the 1q21.1 deletion but were found to carry the 5′ UTR SNP. We identified a 4bp frameshift insertion at the start of the fourth exon in the first case and established that the noncoding SNP and insertion were on different chromosomes; in the second case, we identified a nonsense mutation in the last exon of RBM8A (Fig. 1b,c) . Both mutations were absent from 458 exome samples of the 1000 Genomes Project 11 and 416 samples from the Cohorte Lausannoise (CoLaus) 12 . We conclude that, in the vast majority of cases, compound inheritance of a rare null allele (containing a deletion, frameshift mutation or encoded prema ture stop codon) and one of two lowfrequency noncoding SNPs in RBM8A causes TAR syndrome. On the basis of the genetic results, we postulated a hypomorphic mechanism for TAR, in which one copy of the RBM8A gene is not functional, due to a null allele, and expression of the other copy is reduced, as a result of noncoding SNPs in the 5′ UTR or first intron. Analysis of histone modifications in seven human cell lines from the ENCODE project indicated that both SNPs are localized to poten tial active regulatory elements (Fig. 1d,e) 13 . Annotation of open chromatin structure using the formaldehydeassisted isolation of regulatory elements (FAIRE) technique combined with sequencing (FAIREseq) provided additional evidence of this in megakaryocytes (Fig. 1f) 14 . Computational predictions suggest that the 5′ UTR SNP introduces a binding site for the transcriptional repressor EVI1 and that the intronic SNP disrupts a binding site for the transcription factors MZF1 and RBPJ (Fig. 1g) . The prediction of EVI1 binding was confirmed by electrophoretic mobility shift assays (EMSAs) in the megakaryocytic cell line CHRF28811 (also known as CHRF), in which the EVI1 protein bound the minor allele but only weakly associated with the major allele (Fig. 2a) . EMSA studies for the intronic SNP showed decreases in the binding of nuclear proteins to the minor allele, although we could not confirm the presence of either MZF1 or RBPJ in supershift experiments (Supplementary Fig. 2 ). The results of luciferase reporter assays in cell lines representative of megakaryocytes and osteoblasts showed that the differential bind ing detected by EMSA was functionally relevant and that both the 5′ UTR and intronic SNPs significantly reduced RMB8A promoter activity. The minor alleles, relative to the corresponding major alleles, were associated with significantly lower luciferase activity in human megakaryocytic CHRF and DAMI cell lines and the mouse osteoblast cell line MC3T3 (Fig. 2b) . No effect of the minor allele of the 5′ UTR SNP was observed in human endothelial EAHY926 and HEK293 cells; the minor allele of the intronic SNP did exert an effect in HEK293 cells but not in EAHY926 cells (Fig. 2b) . We next performed immu noblot staining of platelet lysates from three TAR cases (Unique Case Number (UCN) 10, 13 and 16, all with the 1.q21.1 deletion and 5′ UTR SNP combination) and their parents and an additional four cases for whom parental samples were not available: three with the 1.q21.1 deletion and either the 5′ UTR SNP (UCN 83 and 113) or the intronic SNP (UCN 64) and one with the 4bp insertion in RBM8A in combination with the 5′ UTR SNP (UCN 33) ( Supplementary  Fig. 3 ). Densitometry analysis of the protein blots showed a signifi cant reduction in the levels of Y14, the protein encoded by RBM8A, in TAR cases compared to parents and healthy controls (Fig. 2c) . Taken together, the genetic and biological data strongly support our Figure 2 Effect of the regulatory SNPs on transcription factor binding, RBM8A promoter activity and protein expression in platelets. (a) EMSAs with nuclear protein extracts from the megakaryocytic cell line CHRF-288-11. Nuclear protein showed higher affinity for the probe with the A allele (lane 7) than the probe with the G allele (lane 2) of the 5′ UTR noncoding SNP. Binding of the A-allele probe was competed by a specific, unlabeled probe (100× A; lane 8) but not by a nonspecific, G-allele probe (100× G; lane 9). We observed a supershift with an antibody to EVI1 in DNA-protein complexes with the A-allele probe (lane 10), indicating that the minor allele of the 5′ UTR SNP increases binding affinity for the transcription factor EVI1 in vitro. (b) Luciferase reporter assays in cell lines representative of megakaryocytes (CHRF and DAMI) and osteoblasts (MC3T3). Top, schematic of the luciferase reporter construct with the 5′ UTR and intronic SNPs represented by circle and square symbols, respectively. Bottom, there was significantly decreased RBM8A promoter activity for the minor alleles of both the 5′ UTR and intronic noncoding SNPs relative to the major alleles. No effect of the 5′ UTR SNP was observed in EAHY926 and HEK293 human endothelial cells. Error bars, s.d.; *P < 0.01, **P < 0.001. Statistical analysis was performed using the Tukey-Kramer multiple comparisons test. Luciferase activity was normalized with respect to the construct consisting of the major G allele for both SNPs (indicated by G/G). (c) Densitometry analysis of immunoblot staining for Y14, the protein encoded by RBM8A, in platelet lysates from seven TAR cases, six parents (three with the 1q21.1 deletion, one heterozygous for the 5′ UTR SNP, one homozygous for the 5′ UTR SNP and one compound heterozygous for the 5′ UTR and intronic SNPs) and six controls. Results show significantly reduced Y14 protein levels in TAR cases compared to parental and control samples. Immunoblots are presented in supplementary Figure 3 . Error bars, s.d.; *P < 0.01, NS, not significant. Statistical analysis was performed using the heteroscedastic t test. Only genotype configurations indicated by lines were compared. The minor alleles of the 5′ UTR and intronic SNPs are shown in bold type. a.u., arbitrary units.
npg l e t t e r s hypothesis that TAR results from insufficiency of the Y14 protein.
The results from the luciferase assays suggest that the minor allele of the 5′ UTR SNP may code for decreased transcription relative to the major allele. Expression assays in platelet RNA samples from 12 healthy volunteers heterozygous for the 5′ UTR SNP, however, did not reveal a significant difference between transcript levels of the two alleles (P = 0.91, paired t test on allelic ratios; Supplementary Fig. 4) . Therefore, what the exact mechanism is by which the noncoding SNPs lead to the decreased protein expression observed in TAR cases is still an open question.
We investigated whether there are any variants in strong link age disequilibrium (LD) with either the 5′ UTR or the intronic SNP (Supplementary Fig. 5 ). We could identify no such candidates for the 5′ UTR SNP, and, in haplotype analysis using the four exome sequenced TAR cases carrying the minor allele of the 5′ UTR SNP, this allele was present on at least two distinct haplotype backgrounds. This provides an additional line of evidence that the minor allele of the 5′ UTR SNP is causative in TAR. We did identify a rare noncoding SNP (chr. 1: 145,483,747; C/T) 25 kb upstream of RBM8A in high LD with the intronic SNP; Sanger sequencing confirmed that this variant was present in all 11 genotyped TAR cases carrying the minor allele of the intronic SNP. The data from the ENCODE Project and our own FAIREseq openchromatin data in megakaryocytes indicate that this additional SNP is not located in a regulatory region, whereas the intronic SNP is. Increased protein binding to the minor allele of the intronic SNP further corroborates the assumption that this particular SNP is causative. We cannot exclude the possibility that the 5′ UTR and intronic SNPs are not causative variants in TAR; however, in light of the biological and genetic evidence, we believe this is unlikely.
Y14 is one of the four components of the EJC, which is involved in basic cellular functions, such as nuclear export and subcellular localization of specific transcripts 2, 4 , translational enhancement 5 and nonsensemediated RNA decay (NMD) 1, 3, 4 . The RBM8A transcript is widely expressed 15 and is present in all hematopoietic lineages (Supplementary Fig. 6 ), and its encoded protein sequence is highly conserved between species (Supplementary Fig. 7) . Given the impor tant functions of the EJC, it is likely that a complete lack of Y14 in humans is not viable. Indeed, in Drosophila melanogaster, knockdown of its ortholog tsu leads to major defects in abdomen formation 16 , and we found that knockdown of the orthologous rbm8a transcript in Danio rerio using antisense morpholinos resulted in extreme mal formations and death at 2 d postfertilization (Supplementary Fig. 8 ). These findings are comparable with those from studies of a Xenopus laevis knockdown model of Eif4a3, which encodes an interacting EJC component, showing that EJC has a central role in vertebrate embryo genesis 17 . Considered in this context, our results are compatible with both a doseeffect phenomenon and a lineagedependent deficiency in Y14. The possibility of a doseeffect phenomenon is supported by the observation that simple haploinsufficiency is not sufficient to create an aberrant phenotype, as evidenced by the seemingly healthy carriers of the 1q21.1 deletion. We also did not observe an effect on platelet count for either the 5′ UTR or the intronic SNP in the 403 and 59 individuals from the Cambridge BioResource who carried the minor allele for each SNP, respectively (Supplementary Table 3 ). This suggests that compound inheritance of a null allele together with the minor allele of one of the two regulatory SNPs brings Y14 levels below a critical threshold in certain tissues. The cell line-dependent effect shown in the luciferase assays is likely to be the result of differences in the regulation of RBM8A gene expression by combinatorial binding of transcription factors (including EVI1) in the context of the regula tory SNPs. An additional mechanism by which a deficiency in Y14 (and therefore in EJC function) may not be ubiquitous is suggested by studies showing that NMD not only targets nonsense mRNAs but also regulates physiological mRNA abundance in a genespecific manner (reviewed in ref. 18 ). For example, hematopoieticspecific knockdown in the mouse of Upf2, which encodes a core NMD com ponent, resulted in complete disappearance of the hematopoietic stem cell compartment, whereas more differentiated cells were only mildly affected 19 . Finally, in addition to a tissuedependent effect, it is pos sible that the regulatory SNPs have developmental stage-dependent consequences: in mouse, the Mecom gene encoding Evi1 is expressed in a transient manner in emerging limb buds 20 . This may provide an explanation for the skeletal abnormalities observed in TAR.
In conclusion, we have used DNA sequencing to uncover the genetic basis of TAR syndrome, and we have identified a genetic mechanism of compound inheritance involving a null allele com bined with a lowfrequency regulatory variant. This compound inheritance mechanism reduces Y14 abundance, probably in a cell type-and developmental stage-dependent manner. Whether the same mechanism underlies other Mendelian disorders, in particu lar, other microdeletion syndromes showing variable penetrance and expression, remains to be established, but these results highlight the importance of analyzing regulatory regions for causative muta tions. Although we have shown altered proteinbinding affinity for the minor alleles of the regulatory SNPs, the mechanisms by which these SNPs lead to reduced levels of the Y14 protein in platelets are not clear and may be different for the 5′ UTR and intronic SNPs. Although genetic defects in the minor spliceosome 21, 22 and NMD 23 have been linked to human disease, to the best of our knowledge, TAR syndrome is the first human disorder shown to be caused by a defect affecting one of the four EJC subunits.
URLs. Cambridge BioResource, http://www.cambridgebioresource. org.uk/; The European Genomephenome Archive (EGA), http:// www.ebi.ac.uk/ega/; UK10K, http://www.uk10k.org/; Simple Protocol for annealing oligonucleotides, http://www.piercenet.com/files/ TR0045Annealoligos.pdf.
METHOdS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturegenetics/.
Accession codes. The RBM8A mRNA reference sequence is available at NCBI (NM_005105). Sequencing data have been submitted to the European GenotypePhenotype Archive (EGAD00001000018).
Note: Supplementary information is available on the Nature Genetics website.

ACKNOWLEDGMENTS
We thank C. Langford and P. Ellis for performing the enrichment for the exome sequencing, S. Balasubramaniam for assistance with data processing and the Wellcome Trust Sanger Institute sequencing core for sequencing. We thank V. Mooser from GlaxoSmithKline, G. Waeber and P. Vollenweider from CoLaus and J. Durham, C. Scott and colleagues at the Sanger Institute for providing access to their collection of wholeexome sequencing data for the CoLaus cohort 12 . We thank R. Durbin, B. Göttgens and I. Palacios for comments on the manuscript. This study makes use of data generated by the UK10K Consortium, which were derived from samples from the TwinsUK cohort. A full list of the investigators who contributed to the generation of the data is available from their website (see URLs). Genomic DNA was prepared from whole blood using the guanidine hydrochloride-chloroform method. PCR was performed to amplify exon 1 of RBM8A from genomic DNA and cDNA using AmpliTaq GOLD (Applied Biosystems), dNTPs (800 nM; GE Healthcare) and the primers described in Supplementary Table 2, with the following reaction conditions: 95 °C for 10 min; 95 °C for 15 s and 66 °C for 30 s for 5 cycles, with the temperature of the second step decreasing by 1 °C with each cycle; 95 °C for 15 s and 60 °C for 30 s for 30 cycles; and incubation at of 72 °C for 7 min and then 4 °C. PCR products were purified by spin column (D4014, Zymo Research) and ligated into the pCR2.1TOPO vector (Invitrogen) at 20-25 °C for 2 h. Ligation mix (4 µl) was used to transform chemically competent TOP10 cells (Invitrogen), and cells were plated onto FastMedia Amp XGal Agar (InvivoGen). After overnight growth, white colonies were picked into separate wells of 96well PCR plates, and colony PCR was performed with AmpliTaq GOLD and the primers described in Supplementary qPCR in hematopoietic lineages. cDNA was prepared from leukocyte depleted pellets as described above. cDNA preparation from the other hema topoietic lineage has been described 36 . TaqMan gene expression analysis was performed on cDNA using proprietary reagents, according to the manufactur er's instructions (Applied Biosystems). We used the GAPDH (Hs99999905_m1) and RBM8A (Hs4234933_g1) assays. Assays were conducted in 384well format on a 7900HT Sequence Detection System (Applied Biosystems), and the threshold cycle number (C T ) for GAPDH was subtracted from that of the other genes assayed on that sample (∆C T ) to normalize for reaction loading.
